USE OF ORGANOTYPIC CULTURES OF CORTIS ORGAN TO STUDY THE PROTECTIVE EFFECTS OF ANTIOXIDANT MOLECULES ON CISPLATIN-INDUCED DAMAGE OF AUDITORY HAIR-CELLS
Rd. Kopke et al., USE OF ORGANOTYPIC CULTURES OF CORTIS ORGAN TO STUDY THE PROTECTIVE EFFECTS OF ANTIOXIDANT MOLECULES ON CISPLATIN-INDUCED DAMAGE OF AUDITORY HAIR-CELLS, The American journal of otology, 18(5), 1997, pp. 559-571
Hypothesis: Cisplatin causes the generation of reactive oxygen species
(ROS), which interferes with the antioxidant defense system of Corti'
s organ and results in damage to the hair cells. Background: Cisplatin
is a widely used chemotherapeutic agent with the dose-limiting side e
ffect of ototoxicity. Evidence is accumulating that cisplatin interfer
es with the antioxidant defense system of Corti's organ. Methods: Orga
notypic explants of P-3 rat organ of Corti were the in vitro model sys
tem. Presence of intact auditory hair cells and stereocilia bundle int
egrity was assayed by phalloidin-FITC staining. Fluorescent dye probes
detected H2O2 and intracellular thiol [e.g., glutathione (GSH)]. Spec
trophotometric analysis determined antioxidant enzyme levels. Results:
There was a rapid dose-dependent cisplatin cytotoxicity in the explan
ts after 48 h of exposure. An accumulation of H2O2 and a reduction of
GSH levels were observed within cisplatin-exposed hair cells. L-buthio
nine sulfoximine, an inhibitor of GSH formation, enhanced cisplatin ot
otoxicity, whereas N-6-(2-phenylisopropyl) adenosine, an adenosine ago
nist, elevated antioxidant enzyme levels and ameliorated cisplatin tox
icity. The following molecules protected hair cells from cisplatin-ind
uced damage: GSH; glutathione diethyl ester (GSHe); ebselen (EBS); 4-m
ethylthiobenzoic acid (MTBA); and D-methionine (D-MET). EBS, MTBA, and
D-MET in vitro protection correlates with in vivo protection in rats.
Conclusions: Organotypic culture of Corti's organ has been validated
as a model for studying cisplatin toxicity and for screening otoprotec
tive molecules. Some of the events that contribute to cisplatin's abil
ity to damage auditory hair cells are generation of ROS (e.g., H2O2),
depletion of intracellular GSH, and interference with antioxidant enzy
mes within the cochlea. Agents that bolster the cochlea's antioxidant
system can prevent cisplatin destruction of auditory hair cells. Ident
ified protective agents may prove to be clinically useful in limiting
or completely protecting from cisplatin ototoxicity.